D&A at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's D&A?
- Charles River Laboratories (CRL) reported D&A of $67.15M in Q1 2026.
- How has Charles River Laboratories's D&A changed year-over-year?
- Charles River Laboratories's D&A decreased by 44.2% year-over-year, from $120.36M to $67.15M.
- What is the long-term trend for Charles River Laboratories's D&A?
- Over 4 years (2021 to 2025), Charles River Laboratories's D&A has grown at a 11.0% compound annual growth rate (CAGR), from $265.54M to $403.31M.
- What does D&A mean?
- The non-cash expense representing the wear and tear or expiration of assets over time.
- How do you interpret D&A?
- Higher levels typically indicate a capital-intensive business model or recent significant investments in infrastructure and technology.
- How does D&A compare across companies?
- Standard across all capital-intensive industries.